RÉSULTATS ANNUELS 2025-2026 DU GROUPE LEXIBOOK

Lexibook reports FY2025-26 revenue of €80.0M (+8.1%) with stable operating profit at €8.4M (+3.3%), but net income fell to €7.1M (-3.5%) due largely to FX losses (result financier -€0.2M; change losses ~-€644K). Despite a higher gross margin to 63.9% and EBITDA of €9.9M (+1.6%), guidance is cautious for FY2026-27: activity expected to decline in Q1, the Stitch license slowdown (~36% of revenue) and degraded license-renewal terms, alongside higher logistics/freight costs and only partial FX hedging. The company’s net cash improved materially to €13.6M (from €7.1M), but multiple macro/trade risks (US duties, China relations, Middle East shipping) could pressure margins and growth.

Analysis

This is a classic quality-vs-trajectory split: the current year looks clean only because mix and FX masked the underlying economics. The real tell is that incremental revenue was bought with higher ad spend and royalty burden, so the operating margin profile is not scaling the way a branded-license model should if the franchise were compounding. The cleaner balance sheet and inventory reduction help near-term liquidity, but they also signal a business that is becoming more dependent on sell-through at the same time the licensing engine is losing momentum.

Over the next 1-3 months, the market is likely to focus less on the just-reported year and more on FY27 guidance risk: a weak Q1, tougher contract renewals, and partial FX coverage mean the next inflection is likely margin rather than revenue. Because the business is China-assembled and dollar-linked, any combination of weaker EUR/USD, higher freight, or tariff pressure can force either price increases or gross-margin giveback; for a small-cap importer, there is little negotiating leverage with licensors or retailers. The second-order loser is not just the company itself but any similar license-heavy, Asia-sourced toy/import business with concentrated IP exposure.

The contrarian view is that the move may be only partly deserved: if the Stitch roll-off is a known air pocket and freight normalizes, the current setup can look worse than the medium-term earnings power. But the thesis breaks if management shows materially better renewal economics or a credible replacement license pipeline by the November semiannual update; absent that, this is a de-rating story, not a one-off FX story.

Key Decisions for Investors

• ALLEX: do not chase post-print strength; use any relief rally to trim or initiate a small short for 1-3 months, with downside driven by FY27 guide risk and license roll-off rather than this year's results.
• Pair trade: short ALLEX vs long a more diversified branded consumer name such as HAS or MAT over the next 3-6 months; the spread should work if license renewal terms and freight pressure compress ALLEX margins faster than peers.
• Set a watch item for the 30 Nov 2026 semiannual release: if management confirms a sharper-than-expected Q1 decline or weaker renewal terms, add to the short; if they show order re-acceleration and stable royalties, cover immediately.
• Avoid using the balance-sheet improvement as a bullish signal by itself; the cash build looks supportive, but the real falsifier is sell-through and renewal pricing, not liquidity.
• If freight/tariff headlines worsen before holiday ordering, treat ALLEX as a tactical short against European small-cap consumer discretionary exposure rather than a long-duration fundamental idea.